Co-Authors
This is a "connection" page, showing publications co-authored by Qingxian Cai and Deliang Huang.
Connection Strength
0.773
-
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020 07; 75(7):1742-1752.
Score: 0.219
-
COVID-19: Abnormal liver function tests. J Hepatol. 2020 Sep; 73(3):566-574.
Score: 0.219
-
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 Oct; 6(10):1192-1198.
Score: 0.218
-
Acute Kidney Injury and Early Predictive Factors in COVID-19 Patients. Front Med (Lausanne). 2021; 8:604242.
Score: 0.060
-
Longitudinal changes of liver function and hepatitis B reactivation in COVID-19 patients with pre-existing chronic hepatitis B virus infection. Hepatol Res. 2020 Nov; 50(11):1211-1221.
Score: 0.056